The plasminogen-plasmin system.
Explore this paper's citation graph
Summary
This review of the biochemical properties of the proteins has been conceived as an introduction to these enzymes because their use as therapeutic agents is the subject of other articles in this volume of Progress in Cardiovascular Diseases.
- Type
- review
- Published
- 1991-09-01
- Cited by
- 95
- References
- 285
- OpenAlex
- https://openalex.org/W2086687588
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:36084989
Keywords
Benzamidine, Plasmin, Zymogen, Conformational change, Biophysics
References
- Characterization of tissue plasminogen activator binding proteins isolated from endothelial cells and other cell types.
- Activation of fibrin-bound plasminogen by pro-urokinase and its complementariness with that by tissue plasminogen activator.
- Nucleotide sequence of the streptokinase gene from Streptococcus equisimilis H46A.
- The cell-binding domains of plasminogen and their function in plasma.
- Carbohydrate of the human plasminogen variants. I. Carbohydrate composition, glycopeptide isolation, and characterization.
- Plasmin activity and complement activation during storage of citrated platelet concentrates.
- Genetic polymorphism of human plasminogen.
- Location of the intermediate and high affinity omega-aminocarboxylic acid-binding sites in human plasminogen.
- Binding of tissue plasminogen activator to human aortic endothelial cells.
- Cellular localization of profibrinolysin (plasminogen).
- Thermodynamic properties of the binding of alpha-, omega-amino acids to the isolated kringle 4 region of human plasminogen as determined by high sensitivity titration calorimetry.
- Evolution of blood coagulation and fibrinolysis.
- Inhibition of plasmin by fibrinogen.
- Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
- Molecular abnormality of plasminogen.
- Thrombospondin interaction with plasminogen. Evidence for binding to a specific region of the kringle structure of plasminogen.
- Linkage disequilibrium of plasminogen polymorphisms and assignment of the gene to human chromosome 6q26-6q27.
- The fibrinolytic activity of urine.
- INACTIVATION OF FACTOR Va BY PIASMIN
- Mini-plasminogen: a mechanism for leukocyte modulation of plasminogen activation by urokinase.
Cited by
- CD1lb/CD 18 Mediates the Neutrophil Chemotactic Activity of Fibrin Degradation Product D Domain
- Comparison of uterine protease and protease inhibitors present in the pregnant and non-pregnant llama
- Direct fibrinolytic agents: biochemical attributes, preclinical foundation and clinical potential
- Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis
- Characterisation, development and application of a clinical model of thrombosis and fibrinolysis
- Thrombolytic Therapy: A Comprehensive Review of Its Use in Clinical Medicine. Part II
- Macromolecular Ensembles of External and Internal Fibrinolysis: Ways to Enhance the Thrombolytic Effect (A Review)
- Consistent differences in protein distribution along the longitudinal axis in symptomatic carotid atherosclerotic plaques.
- Thrombomodulin is synthesized by osteoblasts, stimulated by 1,25-(OH)2D3 and activates protein C at their cell membrane.
- Pathophysiological implication of the structural domains of lipoprotein(a).
- 2,7-Bis-(4-Amidinobenzylidene)-Cycloheptan-1-One Dihydrochloride, tPA Stop, Prevents tPA-Enhanced Excitotoxicity Both In Vitro and In Vivo
- Plasmin-induced procoagulant effects in the blood coagulation: a crucial role of coagulation factors V and VIII
- Milk plasmin during bovine mammary involution that has been accelerated by estrogen.
- Tissue Plasminogen Activator Requires Plasminogen to Modulate Amyloid‐β Neurotoxicity and Deposition
- The effect of colostrum intake on blood plasma proteome profile in newborn lambs: low abundance proteins
- Non-enzymatic glycation of lipoprotein(a) in vitro and in vivo.
- Role of annexin II tetramer in plasminogen activation.
- Trends and Future Developments in the Pharmacological Treatment of Acute Ischaemic Stroke
- Rapid-reaction Kinetic Characterization of the Pathway of Streptokinase-Plasmin Catalytic Complex Formation*
- Role of Laminin in Matrix Induction of Macrophage Urokinase-type Plasminogen Activator and 92-kDa Metalloproteinase Expression*
Related papers
- Interaction of streptokinase and human plasminogen. 3. Plasmin and activator activities in reaction mixtures of streptokinase and human plasminogen or human plasmin of various molar ratios.
- Purification of Streptokinase and Human Plasmin and Their Interaction
- Comparative study on the inhibition of plasmin and delta-plasmin via benzamidine derivatives.
- Assay of thrombolytic ('fibrinolytic') mixtures intended for therapeutic use.
- Preparation of a Novel Streptokinase Mutant with Improved Stability
- Direct Activation of Human Plasminogen by Streptokinase∗
- On the reaction of plasmin or plasmin-streptokinase complex with aprotinin or alpha 2-antiplasmin.
- Activation of human and bovine plasminogens by the microplasmin and streptokinase complex.
- Streptokinase--biochemistry and clinical application.